Market price forecast of pazopanib/pazopanib in 2025

Pazopanib is an oral multi-target tyrosine kinase inhibitor mainly used to treat malignant tumors such as advanced renal cell carcinoma and soft tissue sarcoma. This drug achieves anti-tumor effects by inhibiting vascular endothelial growth factor receptor (VEGFR) and interfering with tumor cell proliferation and new blood vessel formation. In recent years, with the emphasis on targeted tumor therapy, pazopanib has achieved good results in clinical application, bringing new hope to many patients.

In China, the original drug of pazopanib has obtained marketing authorization and has been included in the scope of national medical insurance. The medical insurance policy also reimburses patients who meet the indications. The implementation of this policy enables more patients to obtain financial support and thus undergo treatment smoothly. Pazopanib is available in two specifications: 200mg and 400mg in China, and the price per box is about RMB 3,000. Specific costs may vary by hospital and region, and patients are advised to consult their local hospital pharmacy to confirm the latest market price and medical insurance reimbursement before purchasing.

In the international market, the price of pazopanib’s original drug is usually slightly lower than that in China, about RMB 2,000 per box. However, this price may change due to exchange rate fluctuations. At the same time, there are also some generic drug supplies at home and abroad. For example, the ingredients of the generic pazopanib drug produced by a pharmaceutical factory in Bangladesh are basically the same as the original drug and can provide similar therapeutic effects. The price is relatively cheap, about 500 yuan per box. This allows some patients to have more economic considerations when choosing treatment options.

Although generic drugs are often less expensive, patients should fully understand the source and quality of the drug when choosing it to ensure it is safe and effective. In addition, when using pazopanib, patients should undergo standardized treatment according to the guidance of their doctor to obtain the best efficacy. During treatment, it is also very important to regularly monitor adverse reactions, because the drug may cause some side effects, such as high blood pressure, abnormal liver function, and rash.

Reference materials:https://www.votrient.com/